Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease

(MedPage Today) — ORLANDO — Infusions of the investigational monoclonal antibody veligrotug improved symptoms among patients with active and chronic thyroid eye disease, the phase III THRIVE clinical program showed.
By week 15 in 113 patients…

Source link : https://www.medpagetoday.com/meetingcoverage/aace/115658

Author :

Publish date : 2025-05-19 19:34:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease

Senate Dems Urge HHS to Undo Rule Barring Some Public Comments

New Dads, Non-Birthing Partners Less Likely to Get Prenatal Counseling on Vaccines

Related Posts

French Fries Singled Out for Diabetes Risk

Extra-strong nicotine pouches packaged like children’s sweets

FDA Approves Drug for Aggressive Glioma

FDA Approves Brain Tumor Drug Targeting New Mutation

Abstracts Related to Dietary Guidelines Pulled From Meeting, Raising Concerns

Patient Deaths, Inner Scars, and Physicians’ Need to Grieve

French Fries Singled Out for Diabetes Risk

Extra-strong nicotine pouches packaged like children’s sweets

FDA Approves Drug for Aggressive Glioma

FDA Approves Brain Tumor Drug Targeting New Mutation

Abstracts Related to Dietary Guidelines Pulled From Meeting, Raising Concerns

Patient Deaths, Inner Scars, and Physicians’ Need to Grieve

Lithium May Combat Alzheimer’s Disease, Data Suggest

Air Embolism Deaths Tied to Watchman LAA Closure Device Access Systems

Categories

Archives